Bondex Asbestos Trust Fund Claims
Bondex asbestos personal-injury claims are administered through the Specialty Products Holding Corp. Asbestos Personal Injury Trust. The Trust was established under the confirmed Chapter 11 reorganization plan for Specialty Products Holding Corp., Bondex International, Inc., Republic Powdered Metals, Inc. and NMBFiL, Inc. Its Trust Distribution Procedures cover SPHC, Bondex and Republic claims for which the Trust has legal responsibility. Claims Processing Facility, Inc. currently administers Bondex claims.
Bondex Asbestos Trust Facts
| Formal trust structure | Specialty Products Holding Corp. Asbestos Personal Injury Trust |
|---|---|
| Bondex claim program | Bondex Asbestos Personal Injury Trust claims administered under the SPHC TDP |
| Covered reorganizing parties | Specialty Products Holding Corp., Bondex International, Inc., Republic Powdered Metals, Inc. and NMBFiL, Inc. |
| Plan confirmation order | December 10, 2014 |
| Claims administrator | Claims Processing Facility, Inc. (CPF) |
| Current Payment Percentage | 29.5% |
| Payment Percentage effective date | January 4, 2024 |
| Prior Payment Percentage | 22% |
| Mesothelioma Scheduled Value | $80,000 |
| Mesothelioma Average Value | $125,000 |
| Mesothelioma Maximum Value | $300,000 |
| Historical Plan funding commitment | $797.5 million aggregate; historical funding commitment, not current assets |
| Current status | Active |
Bankruptcy and Trust History
The official TDP states that the Trust was established in connection with the Joint Plan of Reorganization of Specialty Products Holding Corp., Bondex International, Inc., Republic Powdered Metals, Inc. and NMBFiL, Inc. The U.S. Bankruptcy Court for the District of Delaware confirmed the Plan by order dated December 10, 2014.
SEC-filed settlement documents describe an aggregate $797.5 million funding commitment for the Asbestos Personal Injury Trust. That figure describes the historical Plan funding arrangement and must not be presented as the Trust’s current asset balance.
The TDP provides for resolution of SPHC Trust Claims, including Bondex Trust Claims and Republic Trust Claims. NMBFiL claims are governed by separate NMBFiL procedures and should not be conflated with Bondex claims.
Disease Levels and Claim Values
The official SPHC TDP publishes the following Scheduled, Average and Maximum Values for domestic claims:
| Disease Level | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| Mesothelioma — Level VIII | $80,000 | $125,000 | $300,000 |
| Lung Cancer 1 — Level VII | $33,333 | $50,000 | $120,000 |
| Lung Cancer 2 — Level VI | None | $9,250 | $22,000 |
| Other Cancer — Level V | $6,667 | $10,000 | $24,000 |
| Severe Asbestosis — Level IV | $16,667 | $25,000 | $60,000 |
| Asbestosis/Pleural Disease — Level III | $2,500 | Not stated | Not stated |
| Asbestosis/Pleural Disease — Level II | $800 | Not stated | Not stated |
| Other Asbestos Disease — Level I | $70 Cash Discount Payment | Not applicable | Not applicable |
The TDP permits the Trust, with required consent, to change valuation amounts for good cause after the Initial Claims Filing Date. Accordingly, these figures are identified as the published TDP values rather than guaranteed claim outcomes.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Current 29.5% Payment Percentage
Claims Processing Facility published an official Bondex notice on January 11, 2024 stating that the Trustees approved an increase in the Payment Percentage from 22% to 29.5%, effective January 4, 2024.
The Payment Percentage is applied to the liquidated value of an allowed claim under the TDP. It is designed to preserve substantially equivalent treatment for present and future claimants as Trust assets and projected liabilities change.
Mathematical illustration only — not a guaranteed payment. The published $80,000 Mesothelioma Scheduled Value × 29.5% = $23,600. The $33,333 Lung Cancer 1 Scheduled Value × 29.5% is approximately $9,833.24. The $6,667 Other Cancer Scheduled Value × 29.5% is approximately $1,966.77.
These calculations illustrate application of the percentage to published Scheduled Values. Actual eligibility, liquidation value, applicable Trust rules and the percentage in force when a claim is paid determine the actual payment.
Expedited and Individual Review
Expedited Review provides standardized liquidation for claims meeting the presumptive medical and exposure criteria for a Disease Level with a Scheduled Value. A qualifying claim is generally liquidated at the Scheduled Value and then subject to the applicable Payment Percentage.
Individual Review permits a claim-specific evaluation when the claimant does not meet all presumptive criteria or seeks individualized valuation where permitted. The Trust determines the liquidated value and then applies the applicable Payment Percentage.
Lung Cancer 2 has no Scheduled Value and is handled through Individual Review. Average and Maximum Values are valuation benchmarks; they are not promised payments.
Medical and Exposure Requirements
The TDP requires disease-specific medical proof and qualifying Debtor Exposure. For several Expedited Review levels, including Severe Asbestosis and Asbestosis/Pleural Disease Level III, the TDP requires at least six months of Debtor Exposure before December 31, 1982 together with Significant Occupational Exposure and supporting medical evidence.
Level II requires a qualifying bilateral asbestos-related nonmalignant disease, six months of Debtor Exposure before December 31, 1982 and five years of cumulative occupational asbestos exposure. Level I requires a qualifying asbestos-related condition and Debtor Exposure before December 31, 1982.
The official Bondex Claim Form instructions require valid medical documentation supporting the alleged injury and documentation establishing exposure to asbestos-containing products for which one or more SPHC Parties has legal responsibility.
Current Claim Filing Process
CPF’s official Bondex Claim Form page states that claims can be filed using a paper claim form or electronically through the CPF e-File system. Pro se claimants must file paper claims.
The standardized claim form must be completed and certified. Medical documentation and qualifying product-exposure documentation must accompany the claim, and the filing must comply with the applicable deadline in TDP Section 5.1(a)(2).
CPF currently provides Bondex claim forms, filing instructions, the TDP, product information, presumptive occupational information, deficiency codes, ADR procedures and other Trust-specific materials.
Important Bondex Claim Distinctions
The formal TDP covers SPHC, Bondex and Republic claims, while NMBFiL claims are governed by separate NMBFiL Trust Distribution Procedures. This page therefore does not apply NMBFiL’s separate payment percentage or filing rules to Bondex claims.
The $797.5 million figure in SEC-filed settlement materials is historical Plan funding, not current Trust assets.
The 29.5% Payment Percentage is not itself a disease value. It is applied to an allowed claim’s liquidated value under the TDP.
Current official CPF materials reviewed for this build did not expose a sufficiently current audited 2025 or 2026 financial report from which total assets, cumulative paid claims and lifetime dollars paid could be independently verified. Those figures are therefore omitted rather than copied from law-firm or lead-generation websites.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for this page. Primary claims-administrator, Trust and SEC-filed materials reviewed include:
- Claims Processing Facility, Inc., official Bondex claims administrator.
- Official CPF Bondex TDP resource page.
- Specialty Products Holding Corp. Asbestos Personal Injury Trust Distribution Procedures.
- Official CPF Bondex Payment Percentage change notice.
- Official Bondex Claim Form and filing requirements.
- Official CPF Bondex forms and Trust documents.
- SEC-filed SPHC settlement and Trust funding documents.
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Filing and Eligibility
Payments and Trust Rules
Frequently Asked Questions About the Bondex Asbestos Trust
What trust handles Bondex asbestos claims?
Bondex claims are handled through the Specialty Products Holding Corp. Asbestos Personal Injury Trust under the SPHC Trust Distribution Procedures.
Is the Bondex asbestos claim program active?
Yes. Claims Processing Facility, Inc. continues to provide Bondex claim forms, filing materials, Trust procedures and claim administration.
What is the current Bondex Payment Percentage?
The Trustees increased the Payment Percentage from 22% to 29.5%, effective January 4, 2024.
What is the Bondex mesothelioma value?
The TDP lists an $80,000 Scheduled Value, $125,000 Average Value and $300,000 Maximum Value for Mesothelioma Level VIII.
What does 29.5% of the mesothelioma Scheduled Value equal?
$80,000 multiplied by 29.5% equals $23,600. This is a mathematical illustration only — not a guaranteed payment.
Can Bondex claims receive Individual Review?
Yes. The TDP provides Individual Review for qualifying claims, and Lung Cancer 2 is evaluated through Individual Review because it has no Scheduled Value.
What evidence must be submitted with a Bondex claim?
The official claim instructions require medical documentation supporting the asbestos-related injury and documentation establishing exposure to asbestos-containing products for which an SPHC Party has legal responsibility.
Who administers Bondex asbestos claims?
Claims Processing Facility, Inc. administers Bondex claims and provides paper and electronic filing resources.
Get Help Reviewing a Bondex Asbestos Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Prior exposure to a Bondex asbestos-containing product does not automatically establish Trust eligibility or compensation. Eligibility depends on diagnosis, medical evidence, qualifying exposure evidence, current Trust procedures, applicable filing deadlines and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.